RUNX1 and RUNX3 protect against YAP-mediated EMT, stemness and shorter survival outcomes in breast cancer
10.18632/oncotarget.24419
Saved in:
Main Authors: | Kulkarni, M, Tan, T.Z, Sulaiman, N.B.s, Lamar, J.M, Bansal, P, Cui, J, Qiao, Y, Ito, Y |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/173751 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The Study of WT1 and Cathepsin D in Breast Cancer Cells
by: Thanaporn Wae-hayee
Published: (2024) -
The multiple interactions of RUNX with the hippo–YAP pathway
by: Chuang, Linda Shyue Huey, et al.
Published: (2022) -
RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells
by: Brusgard, J.L, et al.
Published: (2020) -
A NON-CANONICAL ROLE FOR RUNX PROTEINS IN THE FANCONI ANEMIA PATHWAY OF DNA REPAIR
by: TAY LAVINA SIERRA
Published: (2015) -
Molecular pathology of RUNX3 in human carcinogenesis
by: Subramaniam, M.M., et al.
Published: (2012)